Analytical validation of commercial immunoassays for the measurement of cardiovascular peptides in the dog

Veterinary Journal

Volumn 178, Issue 1, 2008, Pages 85-90

  Schellenberg, Stefan ^a   Grenacher, Beat ^a   Kaufmann, Karin ^a   Reusch, Claudia E ^a   Glaus, Tony M ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Big endothelin 1; Brain natriuretic peptide; Canine; Cardiac physiology; Endothelin 1; Immunoassays; Pro atrial natriuretic peptide; Validation

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BIG ENDOTHELIN 1; BRAIN NATRIURETIC PEPTIDE; ENDOTHELIN 1;

ACCURACY; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DILUTION; DOG; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOASSAY; INTERMETHOD COMPARISON; NONHUMAN; RADIOIMMUNOASSAY; RELIABILITY; REPRODUCIBILITY; VALIDATION STUDY;

ANIMALS; BIOLOGICAL MARKERS; DOG DISEASES; DOGS; HEART FAILURE; IMMUNOASSAY; PEPTIDES; REPRODUCIBILITY OF RESULTS;

CANIS FAMILIARIS;

EID: 50449109294     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2007.07.002     Document Type: Article

References (19)

1. Asano K., Masuda K., Okumura M., Kadosawa T., and Fujinaga T. Plasma atrial and brain natriuretic peptide levels in dogs with congestive heart failure. The Journal of Veterinary Medical Science 61 (1999) 523-529
2. Biondo A.W., Wiedmeyer C.E., Sisson D.D., and Solter P.F. Comparative sequences of canine and feline endothelin-1. Veterinary Clinical Pathology 32 (2003) 188-194
3. Boswood A., Attree S., and Page K. Clinical validation of a proANP 31-67 fragment ELISA in the diagnosis of heart failure in the dog. Journal of Small Animal Practice 44 (2003) 104-108
4. Braunwald E., and Bristow M.R. Congestive heart failure: fifty years of progress. Circulation 102 (2000) 14-23
5. Costantino H.R., Langer R., and Klibanov A.M. Solid-phase aggregation of proteins under pharmaceutically relevant conditions. Journal of Pharmaceutical Sciences 83 (1994) 1662-1669
6. Francis G.S. Neuroendocrine activity in congestive heart failure. American Journal of Cardiology 66 (1990) 33D-39D
7. Glaus T.M., Grenacher B., Koch D., Reiner B., and Gassmann M. High altitude training of dogs results in elevated erythropoietin and endothelin-1 serum levels. Comparative Biochemistry and Physiology. Part A, Molecular and Integrative Physiology 138 (2004) 355-361
8. Hall C., Rouleau J.L., Moye L., de Champlain J., Bichet D., Klein M., Sussex B., Packer M., Rouleau J., and Arnold M.O. N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction. Circulation 89 (1994) 1934-1942
9. Ju H.S., Leung S., Brown B., Stringer M.A., Leigh S., Scherrer C., Shepard K., Jenkins D., Knudsen J., and Cannon R. Comparison of analytical performance and biological variability of three bone resorption assays. Clinical Chemistry 43 (1997) 1570-1576
10. MacDonald K.A., Kittleson M.D., Munro C., and Kass P. Brain natriuretic peptide concentration in dogs with heart disease and congestive heart failure. Journal of Veterinary Internal Medicine 17 (2003) 172-177
11. Oikawa S., Imai M., Inuzuka C., Tawaragi Y., Nakazato H., and Matsuo H. Structure of dog and rabbit precursors of atrial natriuretic polypeptide deduced from nucleotide sequence of cloned cDNA. Biochemical and Biophysical Research Communication 132 (1985) 892-899
12. Omland T., Aakvaag A., Bonarjee V.V., Caidahl K., Lie R.T., Nilsen D.W., Sundsfjord J.A., and Dickstein K. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 93 (1996) 1963-1969
13. Pacher R., Stanek B., Hulsmann M., Koller-Strametz J., Berger R., Schuller M., Hartter E., Ogris E., Frey B., Heinz G., and Maurer G. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure. Journal of the American College of Cardiology 27 (1996) 633-641
14. Pousset F., Isnard R., Lechat P., Kalotka H., Carayon A., Maistre G., Escolano S., Thomas D., and Komajda M. Prognostic value of plasma endothelin-1 in patients with chronic heart failure. European Heart Journal 18 (1997) 254-258
15. Prosek R., Sisson D.D., Oyama M.A., Biondo A.W., and Solter P.F. Plasma endothelin-1 immunoreactivity in normal dogs and dogs with acquired heart disease. Journal of Veterinary Internal Medicine 18 (2004) 840-844
16. Scott-Moncrieff J.C., Koshko M.A., Brown J.A., Hill K., and Refsal K.R. Validation of a chemiluminescent enzyme immunometric assay for plasma adrenocorticotropic hormone in the dog. Veterinary Clinical Pathology 32 (2003) 180-187
17. Selvais P.L., Robert A., Ahn S., van Linden F., Ketelslegers J.M., Pouleur H., and Rousseau M.F. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure. Journal of Cardiac Failure 6 (2000) 201-207
18. Tiegten, K., 2004. Bestimmung von "brain natriuretic peptide" (BNP) bei gesunden Hunden. Inaugural-Dissertation Ludwig-Maximilians-Universität München.
19. Thaler M., Metzger J., Schreiegg A., Denk B., Gleixner A., Hauptmann H., and Luppa P.B. Immunoassay for sex hormone-binding globulin in undiluted serum is influenced by high-molecular-mass aggregates. Clinical Chemistry 51 (2005) 401-407